CA
RMD icon

CoreCap Advisors’s ResMed RMD Stock Holding History

CoreCap Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$195 Sell
1
-7
-88% -$1.45K ﹤0.01% 3009
2026
Q1 		$1.8K Buy
8
+5
+167% +$1.25K ﹤0.01% 2437
2025
Q4 		$723 Sell
3
-9
-75% -$2.3K ﹤0.01% 2651
2025
Q3 		$3.29K Buy
12
+6
+100% +$1.64K ﹤0.01% 2278
2025
Q2 		$1.55K Sell
6
-16
-73% -$3.82K ﹤0.01% 2359
2025
Q1 		$4.92K Buy
22
+21
+2,100% +$4.9K ﹤0.01% 2096
2024
Q4 		$229 Sell
1
-35
-97% -$8.43K ﹤0.01% 2712
2024
Q3 		$8.79K Buy
+36
New +$8.04K ﹤0.01% 1827
2024
Q2 		– Sell
-36
Closed -$7.13K – 2372
2024
Q1 		$7.13K Buy
+36
New +$6.6K ﹤0.01% 1830
2022
Q4 		$7.29K Buy
+35
New +$7.69K ﹤0.01% 1643
2022
Q3 		– Sell
-35
Closed -$7K – 1748
2022
Q2 		$7K Buy
+35
New +$7.45K ﹤0.01% 1578
2022
Q1 		– Sell
-35
Closed -$9K – 1743
2021
Q4 		$9K Buy
+35
New +$9.08K ﹤0.01% 1589

Other funds holding RMD

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Addenda Capital Montreal, Quebec, Canada $3.68B AUM 32.88% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

CoreCap Advisors's RMD Position: Q2 2026 in Review

CoreCap Advisors reduced its ResMed (RMD) stake by 88% in Q2 2026, selling an estimated $1.45K and leaving 1 share worth $195. The position accounts for ﹤0.01% of the portfolio, ranked #3009.

CoreCap Advisors first reported a position in RMD in Q4 2021 and has held it in 12 quarters since. The position peaked at $9K in Q4 2021. 139 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • CoreCap Advisors held 1 share of ResMed worth $195 as of Q2 2026.
  • CoreCap Advisors sold 7 ResMed shares in Q2 2026, an estimated $1.45K.
  • ResMed made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #3009 holding.
  • CoreCap Advisors first reported a position in ResMed in Q4 2021 and has held it in 12 quarters since.
  • CoreCap Advisors's ResMed position peaked at $9K in Q4 2021.
  • 139 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.